Ind-Swift Laboratories is trading at ₹409.30, up 5.29%, with no verified company-specific announcement explaining the October 1 rise. - The company’s September 30 AGM was reported, but no link to the price move is established. - The previous session’s healthcare sell-off followed Supreme Court questions about medicine-price markups; the Nifty Healthcare index fell 2.57%. That sector weakness does not explain the October 1 gain, which remains unclear.